Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1996-01-17
1998-04-28
Achutamurthy, Ponnathapura
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
4241931, 530328, G01N 3353, A61K 39385, A61K 3804
Patent
active
057443165
ABSTRACT:
The invention relates to the identification of complexes of human leukocyte antigen molecules and tyrosinase derived peptides on the surfaces of abnormal cells. The therapeutic and diagnostic ramifications of this observation are the subject of the invention.
REFERENCES:
patent: 4898814 (1990-02-01), Kwon
patent: 5487391 (1996-01-01), Boon-Falleur
van der Bruggen et al., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Sci. 254: 1643-1647, see Abstracat, p. 1643, col. 1, third sentence, second paragraph, Dec. 1991.
Greenberg, Therapy of murine leukemia with cyclophosphamide and immune lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia, J. Immunology, Vo. 136, No. 5, p. 1917, col. 2, 1st sentence of the 1st paragraph, Mar. 1986.
Ruppert et al., Multiple transcripts of the mouse tyrosinase gene are generated by alternative splicing, The EMBO J. vol. 7, No. 9, pp. 2715-2722, p. 2715, col. 1, lines 5-7, Jun. 1988.
Traversari, et al., Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes, Immunogenetics 35: 145-152, Abstract, first sentence, p. 146, col. 2, "CTL clones", p. 147, column 1, Sc, 1992.
Brichard, et al, "The Tyrosinase Gene Codes for an Antigen Recognized by Autologous Cytolytic T Lymphocytes on HLA-A2 Melanomas", J. Exp. Med. 178: 489-495 (1993).
Coulie, et al, "Genes Coding For Tumor Antigens Recognized by Human Cytolytic T Lymphocytes", J. Immunotherapy 14: 104-109 (1993).
Slingluff, et al, "Recognition of Human Melanoma Cells by HLA-A2.1 Restricted Cytotoxic T Lymphocytes As Medicated By At Least Six Shared Peptide Epitopes", J. Immunol. 150(7): 2955-2963 (Apr. 1, 1993).
Barinaga, "Getting Some `Backbone`: How MHC Binds Peptides" Science 257: 880-881 (Aug. 14, 1992).
Falk, et al, "Allele Specific Motifs revealed by sequencing of self-peptides eluted from MHC molecules", Nature 351: 290-296 (May 23, 1991).
Wolfel, et al, "Lysis of Human Melanoma Cells by Autologous Cytolytic T Cells Clones", J. Exp. Med. 170: 797-810 (Sep. 1989).
Boon-Falleur Thierry
Brichard Vincent
Lethe Bernard
Pel Aline Van
Wolfel Thomas
Achutamurthy Ponnathapura
Ludwig Institute for Cancer Research
Park Hankyel T.
LandOfFree
Isolated, tyrosinase derived peptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated, tyrosinase derived peptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated, tyrosinase derived peptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1531046